December 25, 2014 9:24 PM ET

Healthcare Equipment and Supplies

Company Overview of Aferrix Ltd.

Company Overview

Aferrix Ltd. engages in the development and applications of tools and technologies for the early diagnosis and management of toxic iron in the serum. Its products including feROS labile plasma iron (eLPI) that detects redox active and inactive fractions of non transferring bound iron (NTBI); and FeRisk directly cheatable iron that detects the fraction of NTBI components that are directly cheatable by deferrioxamine (DFO), including DFO-accessible iron forms. The company’s products also comprise FeRisk NTBI, which measures NTBI in serum or plasma sample; and feROS LPI, which detects the fraction of NTBI that is redox active and susceptible to a selective iron chelator, such as deferriprone. I...

19A Habarzel Street

Ramat Hachayal

Tel-Aviv,  69710

Israel

Founded in 2002

Phone:

972 73 212 6155

Fax:

972 73 212 6144

Key Executives for Aferrix Ltd.

Chief Executive Officer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
UpRight Middle East/Africa
Savyon Diagnostics Ltd. Middle East/Africa
Carevature Medical Ltd. Middle East/Africa
JetGuide Ltd. Middle East/Africa
Assis Medical Ltd. Middle East/Africa

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aferrix Ltd., please visit www.aferrix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.